Global Avian Flu Treatment Market Growth Prospects and Strategic Opportunities Through 2029
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What CAGR And Valuation Are Anticipated For The Avian Flu Treatment Market?
In recent years, there has been significant growth in the avian flu treatment market. It is projected to expand from $12.59 billion in 2024 to $13.77 billion in 2025, with a compound annual growth rate (CAGR) of 9.3%. The historical period’s growth can be credited to the surge in demand for avian flu treatments, heightened actions to curb bird flu transmission, more availability of treatment choices, heightened investment in healthcare infrastructure, and a rise in the demand for poultry consumption.
The market for avian flu treatment is anticipated to experience impressive growth in the coming years, reaching a value of $19.23 billion in 2029 with a compound annual growth rate (CAGR) of 8.7%. Factors contributing to this growth during the prediction period include increasing awareness and diagnosis, government-driven measures for preparation against pandemics, an upswing in investments for research and development, the necessity for efficient therapeutics to fight avian flu, and widespread research and development undertakings. Key tendencies during this period are expected to be the evolution of groundbreaking therapeutic strategies, upcoming innovations and technologies, partnered research initiatives, the emergence of new businesses and investment prospects, and the adoption of telemedicine and remote consultations.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16352&type=smp
What Core Drivers Are Expected To Influence The Avian Flu Treatment Market?
The anticipated expansion of the avian flu treatment market is likely to be fuelled by the increasing levels of awareness and diagnosis. Awareness involves identifying a health problem, while diagnosis pertains to confirming a specific disease based on the initial awareness. The requirement for avian flu treatment is driven by the critical desire to protect public health, preclude possible outbreaks, and prevent substantial economic damage to poultry industries. Critical factors for efficient avian flu treatment are awareness and early diagnosis, enabling swift measures and containment to inhibit the spread. For example, data from the World Health Organization (WHO), a Switzerland-based intergovernmental organization, showed that over 8000 people in the US were under vigilant observation from February 9, 2022, to March 29, 2024, after possible exposure to animals believed to be infected with the HPAI A (H5N1) virus. As a result, the growth of the avian flu treatment market is being steered by the rising levels of awareness and diagnosis.
What Are The Main Segment Classifications In The Avian Flu Treatment Market?
The avian flu treatmentmarket covered in this report is segmented –
1) By Type: Antibiotics; Vaccines; Antiviral Agents; Immunoglobulins
2) By Distribution Channel: Online Pharmacies; Offline Pharmacies
3) By End User: Hospital; Institutional Health Centers; Clinics
Subsegments:
1) By Antibiotics: Broad-Spectrum Antibiotics; Tetracycline Antibiotics; Penicillin-Based Antibiotics; Macrolide Antibiotics; Cephalosporins; Antimicrobial Peptides
2) By Vaccines: Inactivated Vaccines; Live Attenuated Vaccines; Recombinant Vaccines; Subunit Vaccines; Dna Vaccines; Bivalent And Multivalent Vaccines
3) By Antiviral Agents: Neuraminidase Inhibitors (Oseltamivir, Zanamivir); M2 Ion Channel Inhibitors (Amantadine); Polymerase Inhibitors; Protease Inhibitors; Antiviral Combination Therapies
4) By Immunoglobulins: Human Immunoglobulin (Ivig); Monoclonal Antibodies; Hyperimmune Serum; Polyvalent Immunoglobulins; Avian Flu-Specific Immunoglobulins
How Are Market Trends Influencing Competition In The Avian Flu Treatment Market?
Leading players in the avian flu treatment market are strategically forming partnerships to enhance their capability to develop new treatments more effectively and swiftly. These partnerships are typically between pharmaceutical firms, research entities, and governmental agencies, enabling them to consolidate resources, share professional knowledge, and carry out ground-breaking clinical trials. For example, in April 2024, CureVac N.V., a biotechnology firm based in Germany, entered a partnership with GSK plc, a British pharmaceutical corporation, to develop a potential influenza A (H5N1) pre-pandemic vaccine candidate addressing possible future pandemic risks related to the H5N1 avian flu virus. The objective of this partnership is to evaluate the safety, reactogenicity, and immunogenicity of the monovalent vaccine candidate, which encodes an influenza A H5-antigen using CureVac’s proprietary second-generation mRNA backbone. The joined Phase 1/2 study will scrutinize the safety and efficacy of the vaccine candidate in healthy adults aged 18 to 64 as well as older adults aged 65 to 85.
Which Companies Are Contributing Significantly To The Avian Flu Treatment Market Growth?
Major companies operating in the avian flu treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, Gilead Sciences Inc., Baxter International Inc., CSL Limited, Moderna Inc., Cipla Ltd., Shionogi & Co. Ltd., Novavax Inc., Seqirus Pty Ltd., Sinovac Biotech Ltd., Emergent BioSolutions Inc., Dynavax Technologies Corporation, CureVac AG, Valneva SE, BioCryst Pharmaceuticals Inc., Siga Technologies Inc., Aridis Pharmaceuticals Inc., Inovio Pharmaceuticals Inc., Biolyse Pharma
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/avian-flu-treatment-global-market-report
Which Region Holds The Greatest Opportunity For Avian Flu Treatment Market Expansion?
North America was the largest region in the avian flu treatment market in 2024. Asia-Pacific is expected to be the fastest growing region in the market. The regions covered in the avian flu treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=16352&type=smp
Browse Through More Reports Similar to the Global Avian Flu Treatment Market 2025, By The Business Research Company
Sewage Treatment Facilities Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/sewage-treatment-facilities-global-market-report
Benign Prostatic Hyperplasia Bph Treatment Devices And Equipment Global Market Report 2025
Wastewater Treatment Equipment Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
